| 000 | 01154 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515165746.0 | ||
| 264 | 0 | _c20100111 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1534-6277 | ||
| 024 | 7 |
_a10.1007/s11864-009-0091-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDunbar, Erin M | |
| 245 | 0 | 0 |
_aThe role of chemotherapy for pure and mixed anaplastic oligodendroglial tumors. _h[electronic resource] |
| 260 |
_bCurrent treatment options in oncology _cAug 2009 |
||
| 300 |
_a216-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedical Oncology _xmethods |
| 650 | 0 | 4 |
_aOligodendroglioma _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tCurrent treatment options in oncology _gvol. 10 _gno. 3-4 _gp. 216-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11864-009-0091-7 _zAvailable from publisher's website |
| 999 |
_c18813071 _d18813071 |
||